Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Silvia Piantoni

Showing results (11-20 of 62) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|April 14, 2018
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abataceptSilvia Piantoni, Francesca Regola, Mirko Scarsi, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
The Israel Medical Association Journal : IMAJ|July 18, 2012
Antiphospholipid syndrome and antiphospholipid antibodies in children: the two sides of the coinCecilia Nalli, Silvia Piantoni, Laura Andreoli, et al.
Human Vaccines & Immunotherapeutics|May 19, 2022
Belimumab for systemic lupus erythematosus - Focus on lupus nephritisMarlene Plüß, Silvia Piantoni, Björn Tampe, et al.
Clinical and Experimental Rheumatology|February 10, 2015
Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patientsFrancesca Dall'Ara, Laura Andreoli, Nicole Piva, et al.
Clinical and Experimental Rheumatology|March 9, 2021
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et alSilvia Piantoni, Chiara Bazzani, Emirena Garrafa, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2022
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic SclerosisMaria-Grazia Lazzaroni, Silvia Piantoni, Fabrizio Angeli, et al.
Frontiers in Medicine|April 25, 2022
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular DiseasesLiala Moschetti, Silvia Piantoni, Enrico Vizzardi, et al.
Rheumatology (Oxford, England)|May 31, 2020
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory diseaseSilvia Piantoni, Andrea Patroni, Paola Toniati, et al.
Annals of the Rheumatic Diseases|August 29, 2020
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre <i>et al</i>Silvia Piantoni, Enrico Colombo, Roberto Furloni, et al.
Pageof 7

Showing results (11-20 of 62) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|April 14, 2018
Circulating follicular helper T cells (CD4+CXCR5+ICOS+) decrease in patients with rheumatoid arthritis treated with abataceptSilvia Piantoni, Francesca Regola, Mirko Scarsi, et al.
Clinical Rheumatology|January 27, 2016
Predictive factors of abatacept therapy discontinuation in patients with rheumatoid arthritisSilvia Piantoni, Enrico Colombo, Angela Tincani, et al.
The Israel Medical Association Journal : IMAJ|July 18, 2012
Antiphospholipid syndrome and antiphospholipid antibodies in children: the two sides of the coinCecilia Nalli, Silvia Piantoni, Laura Andreoli, et al.
Human Vaccines & Immunotherapeutics|May 19, 2022
Belimumab for systemic lupus erythematosus - Focus on lupus nephritisMarlene Plüß, Silvia Piantoni, Björn Tampe, et al.
Clinical and Experimental Rheumatology|February 10, 2015
Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patientsFrancesca Dall'Ara, Laura Andreoli, Nicole Piva, et al.
Clinical and Experimental Rheumatology|March 9, 2021
Reply to: Anti-carbamylated protein antibodies are associated with early abatacept response in rheumatoid arthritis by Castellanos-Moreira et alSilvia Piantoni, Chiara Bazzani, Emirena Garrafa, et al.
Clinical Reviews in Allergy & Immunology|March 7, 2022
A Narrative Review of Pathogenetic and Histopathologic Aspects, Epidemiology, Classification Systems, and Disease Outcome Measures in Systemic SclerosisMaria-Grazia Lazzaroni, Silvia Piantoni, Fabrizio Angeli, et al.
Frontiers in Medicine|April 25, 2022
Endothelial Dysfunction in Systemic Lupus Erythematosus and Systemic Sclerosis: A Common Trigger for Different Microvascular DiseasesLiala Moschetti, Silvia Piantoni, Enrico Vizzardi, et al.
Rheumatology (Oxford, England)|May 31, 2020
Why not to use colchicine in COVID-19? An oldanti-inflammatory drug for a novel auto-inflammatory diseaseSilvia Piantoni, Andrea Patroni, Paola Toniati, et al.
Annals of the Rheumatic Diseases|August 29, 2020
Anti-inflammatory action of colchicine in hospitalised patients with COVID-19. Response to: 'Colchicine treatment in community healthcare setting to prevent severe COVID-19' by Della-Torre <i>et al</i>Silvia Piantoni, Enrico Colombo, Roberto Furloni, et al.
Pageof 7